Eradication of human papillomavirus and elimination of HPV-related diseases - scientific basis for global public health policies
Introduction: Infections with oncogenic human papillomaviruses (HPV) globally cause about 9% of cancers in females and 1% of cancers in males. HPV disease burden can be effectively controlled by prophylactic HPV-vaccination provided it has high impact. Areas covered: A unique series of biobank-based...
Saved in:
Main Authors: | Matti Lehtinen (Author), Iacopo Baussano (Author), Jorma Paavonen (Author), Simopekka Vänskä (Author), Joakim Dillner (Author) |
---|---|
Format: | Book |
Published: |
Taylor & Francis Group,
2019-02-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Immunopathogenesis of Chlamydial Pelvic Inflammatory Disease: The Role of Heat-Shock Proteins
by: Jorma Paavonen, et al.
Published: (1994) -
The cost-effectiveness profile of sex-neutral HPV immunisation in European tender-based settings: a model-based assessment
by: Venetia Qendri, MSc, et al.
Published: (2020) -
Detection of Human Papillomavirus DNA by AffiProbe HPV-DNA Test Kit in Cervical Scrapes or Biopsies-Histopathologic Correlates
by: Pekka Nieminen, et al.
Published: (1994) -
Aspects of Prophylactic Vaccination against Cervical Cancer and Other Human Papillomavirus-Related Cancers in Developing Countries
by: Kari Natunen, et al.
Published: (2011) -
Towards the elimination and eradication of hepatitis B
by: Geoffrey Dusheiko
Published: (2015)